Citations 1
Adjuvant Pazopanib Does Not PROTECT Against Recurrence of High-Risk, Initially Localized Renal Cell Cancer but Does Provide Novel Insights
Stewart, Grant D. , Leibovich, Bradley C. , Négrier, Sylvie , Figlin, Robert A.
Journal of Clinical Oncology | October 25, 2017 | Volume: 35 | Issue: 35 | Pages: 3895-3897
